AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DROTAVERINE

10 registrations across 3 African markets— 10 active

Markets with DROTAVERINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
DROTAVERINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaM.J.BIOPHARM PVT LTDactive
NO-SPA
SOLUTION INJECTABLE
🇲🇦Moroccoactive
DROTAVERINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaM.J.BIOPHARM PVT LTDactive
NO-SPA
COMPRIME
🇲🇦Moroccoactive
NO-SPA
COMPRIME
🇲🇦Moroccoactive
DROTAVERINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaM.J.BIOPHARM PVT LTDactive
DROTAVERINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaM.J.BIOPHARM PVT LTDactive
REGULIX
comprimé / 40 mg
🇸🇳SenegalBDA PHARMA PVT LTDactive
NO-SPA
COMPRIME
🇲🇦Moroccoactive
REGULIX
comprimé / 80 mg
🇸🇳SenegalBDA PHARMA PVT LTDactive

DROTAVERINE in Africa — Regulatory Overview

DROTAVERINE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Uganda, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.